Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: Results about 56 cases;Chimiotherapie premiere par le protocole T10 de Rosen avant chirurgie conservatrice dans les osteosarcomes primitifs des membres: Resultats a propos de 56 cas

Bulletin du Cancer

Volumn 87, Issue 2, 2000, Pages 183-188

  Boussen, Hamouda ^a   Mezzi, Frej ^a   Gamoudi, Amor ^a   Daldoul, Olfa ^a   Ben Hamida, Hamadi ^b   Mezlini, Amel ^a   Khalfallah, S ^a   Karray, Slah ^c   Ben Romdhane, Khaled ^a   Ben Ghachem, Maher ^b   Ben Abdallah, Mansour ^a   Douik, Mongi ^c   Saadi, Amor ^a   Ben Hassine, H ^d   Ben Ayed, Farhat ^a  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b CHILDREN S HOSPITAL   (Tunisia)

^c Institut National Mohammed Kassab d'Orthopedie   (Tunisia)

^d Hopital Aziza Othmana   (Tunisia)

Author keywords

Chemotherapy; Osteosarcoma

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; DOXORUBICIN; METHOTREXATE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; FOLINIC ACID; LACTATE DEHYDROGENASE; T7 PROTOCOL; TUMOR MARKER; VINCRISTINE;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; OSTEOSARCOMA; PROGNOSIS; SCHOOL CHILD; SKIN TOXICITY; SURVIVAL RATE; TUMOR VOLUME; TUNISIA; ADJUVANT CHEMOTHERAPY; ANALYSIS OF VARIANCE; BLOOD; BONE TUMOR; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LEUCOVORIN; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; OSTEOSARCOMA; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 0034132596     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1. Malawer MM, Link MP, Donaldson S. Sarcomas of bone. In : Principles and practice in oncology. De Vita VT, ed. Philadelphia. Lippincott. 1997; 1789-852.
2. 2. Rosen G. Neoadjuvant chemotherapy for osreogenic sarcoma : a model for the treatment of other highly malignant neoplasms. Cancer 1986 ; 58:148-56.
3. 3. Kalifa C, Razafindrakoto H, Vassal G, et al. Chemotherapy in osteogenic sarcoma : the experience of the Gustave-Roussy Institute. Cancer Treat Res 1993; 62: 347-9.
4. 4. Bacci G, Ferrari S, Mercuri M, et al. Neoadjuvant chemotherapy for extremity osteosarcoma : preliminary results of the Rizzoli's 4th study. Acta Oncologica 1998 ; 37 : 41-8.
5. 5. Saeter G, Elomaa I, Wahlqvist Y, Alvegard TA, Wiebe T, Monge O, et al. Prognostic factors in bone sarcomas. Acta Orthop Scand Suppl 1997 ; 273 : 156-60.
6. 6. Bacci G, Ferrari S, Delepine N, et al. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity : study of 272 patients preoperatively treated with high dose methotrexate, adriamycin and cisplatin. J Clin Oncol 1998 ; 16 : 658-63.
7. 7. Davis AM, Belle RS, Goodwin PJ. Prognostic factors in osteosarcoma : a critical review. J Clin Oncol 1994 ; 12 : 423-31.
8. 8. Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstruction procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 1993 ; 286 : 241-6.
9. 9. Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997 ; 80 : 2321-32.
10. 10. Link MP, Eilber F. Osteosarcoma. In : Principles and practice of pediatric oncology. Third edition. Philadelphia. Lippincott. 1997 ; 889-920.
11. 11. Ben Abdallah M. Épidémiologie des cancers en Tunisie. Registre de l'institut Salah Azaïz, Tunis, 1997.
12. 12. Finn HA, Simon MA. Limb salvage surgery in the treatment of osteosarcoma in skeletally immature individuals. Clinical Orthop 1991 ; 262 : 108-18.
13. 13. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980 ; 153 : 106.
14. 14. Dubousset J, Missenard G, Kalifa C. Management of osteogenic sarcoma in children and adolescents. Clin Orthop 1991 ; 270 : 52-9.
15. 15. Kandioler D, Kromer E, Tuchler H. Long-term results after repeated surgical removal of pulmonary metastases. Annal Thorac Surg 1998 ; 65 : 909-12.
16. 16. Rosen G, Caparros B, Huvos A, et al. Preoperative chemotherapy for osteogenic sarcoma : selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49 : 1221-30.
17. 17. Saeter G, Alvegard TA, Elomaa I, Stenwig AE, Holmstiom T, Solheim OP. Treatment of osteosarcoma of the extremities with the T10 protocol with emphasis on the effects of preoperative chemotherapy with single agent-high dose methotrexate : a Scandinavian Sarcoma Group Study. J Clin Oncol 1991 ; 9 : 1766-75.
18. 18. Meyers PA, Heller G, Healy J. Chemotherapy for non metastatic osteogenic sarcoma : the Memorial Sloan Kettering Experience. J Clin Oncol 1992; 10 : 5-15.
19. 19. Bieling P, Rehan N, Winkler P. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996 ; 14 : 848-58.
20. 20. Bacci G, Ferrari S, Delepine N, et al. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity : study of 272 patients preoperatively treated with high dose methotrexate, adriamycin and cisplatin. J Clin Oncol 1998 ; 16 : 658-63.
21. 21. Ferrari S, Bacci G, Picci P, et al. Long term follow-up and post-relapse survival in patients with non-metasratic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol 1997 ; 8 : 765-71.
22. 22. Jaffe N, Prudich J, Knapp L. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol 1983 ; 1 : 428-31.
23. 23. Souhami RL, Graft AW, Van Der Eijcken J, et al. Randomized trial of two regimens of chemotherapy in operable osteosarcoma : a Study of the European Osteosarcoma Intergroup. Lancet 1997 ; 350 : 911-7.
24. 24. Genter JC, Brunat-Mentigny M, Demaille MC, et al. Ifosfamide and etoposide in childhood osteosarcoma : a phase II study of the French Society of Pediatric Oncology. Eur J Cancer 1997 ; 33 : 232-7.
25. 25. Delepine N, Delepine G, Bacci G, Rosen G, Desbois JC. Influence of methotrexate dose-intensity on outcome of patients with high grade osteogenic sarcoma. Cancer 1996 ; 78 : 2127-35.
26. 26. Bramwell VH. The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma. Semin Oncol 1997 ; 24 : 561-71.
27. 27. Bielack SS, Kempf-Bielack B, Winkler K. Osteosarcoma : relationship of response to preoperative chemotherapy and type of surgery to local recurrence. J Clin Oncol 1996 ; 14 : 683.
28. 28. Felder-Puig R, Fordma AK, Mildner A, et al. Quality of life and psychosocial adjustement of young patients after treatment of bone cancer. Cancer 1998 ; 83 : 69-75.
29. 29. Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer 1997 ; 80 : 960-5.